Use of HMGB polypeptides for increasing immune responses

Details for Australian Patent Application No. 2003295653 (hide)

International Classifications

Event Publications

22 April 2004 Complete Application Filed

Priority application(s): 60/427,848 20.11.02 US

15 July 2004 Application Open to Public Inspection

Published as AU-B-2003295653

16 August 2007 Application Accepted

Published as AU-B-2003295653

16 August 2007 Change of Name(s) of Applicant(s), Section 104

North Shore-Long Island Jewish Research Institute The name of the applicant has been changed to Feinstein Institute of Medical Research Change of Name(s) of Applicant(s), Section 104 2004

13 September 2007 Change of Name(s) of Applicant(s), Section 104

Feinstein Institute of Medical Research The name of the applicant has been changed to The Feinstein Institute of Medical Research 2004

20 December 2007 Standard Patent Sealed

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.